H Karsai
Overview
Explore the profile of H Karsai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Osoba D, Murray N, Gelmon K, Karsai H, Knowling M, Shah A, et al.
Oncology (Williston Park)
. 1994 Apr;
8(4):61-5; discussion 65-6, 69.
PMID: 8003398
Quality of life was assessed by self-report questionnaires in 30 patients receiving dose-intensive chemotherapy for either non-small-cell lung cancer (20 patients) or recurrent head and neck cancer (10 patients). Megestrol...
2.
Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy
Osoba D, Murray N, Gelmon K, Karsai H, Knowling M, Shah A, et al.
Oncology (Williston Park)
. 1994 Mar;
8(3):43-9; discussion 49-50, 52.
PMID: 7517169
Megestrol acetate was given daily to lung cancer patients undergoing therapy with CODE and to recurrent head and neck cancer patients receiving DEB/M in an attempt to prevent weight loss....
3.
Murray N, Shah A, Osoba D, Page R, Karsai H, Grafton C, et al.
J Clin Oncol
. 1991 Sep;
9(9):1632-8.
PMID: 1651995
The regimen of cisplatin, vincristine, doxorubicin, and etoposide (CODE) was designed to double the dose intensity of these drugs in comparison with a standard regimen (alternating cyclophosphamide, doxorubicin, and vincristine...
4.
Murray N, Osoba D, Shah A, Page R, Karsai H, Little C
J Natl Cancer Inst
. 1991 Feb;
83(3):190-4.
PMID: 1846431
Fifty-three patients, 17 with stage IIIB and 36 with stage IV non-small-cell lung cancer, were given CODE (cisplatin, vincristine, doxorubicin, and etoposide) plus antibiotic prophylaxis and an antiemetic regimen in...
5.
Karsai H, Coldman A, Gavin D, Brumelle S, Boyes D, Anderson G, et al.
CMAJ
. 1988 Oct;
139(8):733-6.
PMID: 3167733
The annual incidence rates of cervical intraepithelial neoplasia (CIN), grades I to III, from 1975 to 1983 among 2440 prisoners in British Columbia for whom a history of screening by...
6.
Stark B, Hershko C, Rosen N, CIVIDALLI G, Karsai H, Soffer D
Cancer
. 1984 Nov;
54(10):2109-21.
PMID: 6488137
Eleven patients with familial hemophagocytic lymphohistiocytosis (FHLH) are described. They all belonged to four Jewish families of Iranian and Iraqi origin. Parental consanguinity was found in three families. The age...
7.
ABRAMOWITZ A, SAMUELS L, Morag A, Karsai H
Pediatr Radiol
. 1981 Jan;
11(4):219-20.
PMID: 6275333
No abstract available.